Sampling protocol for research CSF samples
Research CSF sampling was performed in the morning (before 12.00 a.m.) via lumbar puncture. All subjects were subjected to overnight fasting from at least 8 hrs before the lumbar puncture and were only allowed water prior to the lumbar puncture. Subjects underwent a neurological examination prior to the lumbar puncture to check for contraindications for lumbar puncture. The procedures were performed by six, highly experienced Resident doctors in Neurology. Subjects were positioned in the left lateral recumbent kneesto-chest position. For disinfection of the skin Chlorhexidine (5g/L)/denatured ethanol 70% (Pharmacy LUMC, art. no. 909602) was used. CSF samples were taken via lumbar puncture between the L3/L4 or L4/L5 interspace with a Medi Plast 0.9(20G) x 90-mm traumatic needle.
After penetrating the subarachnoid space the intracranial pressure was measured with a CSF manometer (Medisize B.V., art. no GDO02*S-A). For routine CSF diagnostics 3 mL CSF was sampled in a 12-mL polystyrene tube (Greiner, art. no. 160172).
Three different sample handling protocols were used for preparation of samples for MS-based metabolomics (methods 1 and 2) as well as for NMR-based metabolomics (method 3). All research samples were handled exactly the same way after sampling and all sample handling steps were carried out on ice.
For sampling method 1, 6 mL of cold ethanol (J.T.Baker, ethanol absolute, prod. no. 8098) was added to a 15-mL polypropylene falcon tube (Greiner, art.no. 188271) and placed on ice.
Subsequently, 3.0 mL of CSF was sampled directly into this tube and inverted several times to mix thoroughly with the ethanol. Directly after sampling the CSF/Ethanol mixture was divided in 1.5-mL aliquots into 7 x 1.8-mL labeled cryotubes (Nunc 1.8-ml cryotubes -art.
no. 368632), and placed on dry ice.
For sampling method 2, 3.8 mL of CSF was sampled in a 15-mL polypropylene falcon tube and centrifuged at 4 o C for 5 minutes (2000 rpm, 747 g) directly after sampling. Following centrifugation, the supernatant from this tube was transferred to a 15-mL polypropylene falcon tube, and divided in 0.5-mL aliquots, into 7 x 1.8-mL cyrotubes (Nunc, 1.8-ml cryotubes -art.no. 368632) already containing 1 mL of cold ethanol. The aliquots were 3 repeatedly inverted to mix thoroughly and placed on dry ice.
For sampling method 3, 4.8 mL of CSF was sampled directly in a 15-mL polypropylene falcon tube and centrifuged at 4 o C for 5 minutes (2000 rpm, 747 g) directly after sampling.
Following centrifugation, the supernatant was transferred to a 15-mL polypropylene falcon tube, then divided in 0.5-mL aliquots into 8 x 1.0-mL cryotubes (Nunc 1.0-mL cryotubes -art.
no. 366656), and placed on dry ice.
All sample aliquots were placed on dry ice within 30 minutes from sampling and were transferred to -80 o C for storage within 60 minutes from sampling. All samples remained at -80 o C until sample preparation, no extra freeze-thaw cycles were allowed.
Sampling protocol for clinical CSF samples
Clinical CSF samples were collected at the Neurology outpatient clinic at the Leiden 
